SELUTION 4 De Novo Small Vessel IDE Trial

NARecruitingINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2031

Conditions
Coronary Artery Disease
Interventions
DEVICE

PCI with SELUTION SLR DCB

After target lesion pre-dilatation and preparation , a SELUTION SLR 014 PTCA DEB study device should be selected with nominal diameter equal to the RVD of the target lesion (1:1 ratio) and length that allows approximately 2.00 mm longer than the proximal and distal edges of the target lesion (defined as the proximal and distal extent of predilation). If IVUS is performed to assess RVD, and DEB upsizing is deemed clinically necessary for optimal results, a maximum nominal DEB diameter of 3.0 mm is permitted. The SELUTION SLR 014 PTCA DEB should then be delivered, positioned in and deployed per instructions per use. The balloon should be inflated for 60 seconds provided that the patient can tolerate this duration. The minimum inflation time is 30 seconds.

DEVICE

"PCI with FDA approved -limus DES"

"For subjects randomized to the control group (DES), the treating physician will choose an FDA cleared DES and follow lesion preparation and stent deployment according to the Instructions per use (IFU) and institutional practices.~The DES should be sized per IFU with respect to the vessel RVD. The use of IVUS or OCT is encouraged to guide optimal stent placement and assess final results. After DES deployment, additional balloon inflations should be performed as needed to obtain \< 30% residual diameter stenosis and resolve proximal or distal edge dissections greater than or equal to NHLBI grade B."

Trial Locations (43)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

17033

RECRUITING

Penn State Health Hershey & Berks, Hershey

17050

RECRUITING

UPMC Pinnacle, Mechanicsburg

20010

RECRUITING

MedStar Washington Hospital Center, Washington D.C.

21287

WITHDRAWN

Johns Hopkins, Baltimore

23225

RECRUITING

HCA Chippenham, Richmond

27607

RECRUITING

NC Heart and Vascular, Raleigh

30033

RECRUITING

Atlanta VA, Atlanta

30309

RECRUITING

Piedmont Heart Institute, Atlanta

30322

RECRUITING

Emory, Atlanta

31792

RECRUITING

Archbold Memorial Hospital, Thomasville

32209

RECRUITING

University of Florida, Jacksonville, Jacksonville

32803

RECRUITING

AdventHealth Orlando, Orlando

33462

WITHDRAWN

HCA Florida JFK, Atlantis

33770

RECRUITING

HCA Largo, Largo

34695

RECRUITING

Mease Countryside Hospital, Clearwater

37203

RECRUITING

HCA Centennial, Nashville

45219

RECRUITING

The Lindner Research Center at Christ, Cincinnati

53215

RECRUITING

Advocate Aurora St. Luke's, Milwaukee

55407

RECRUITING

Minneapolis Heart Institute, Minneapolis

55417

RECRUITING

Minneapolis VA Medical Center, Minneapolis

60453

RECRUITING

Advocate Christ Medical Center, Oak Lawn

60515

RECRUITING

Advocate Good Samaritan Hospital, Downers Grove

67226

RECRUITING

Cardiovascular Research Institute of Kansas, Wichita

70360

RECRUITING

Cardiovascular Institute of the South, Houma

72401

RECRUITING

St. Bernards, Jonesboro

75093

RECRUITING

Baylor Scott and White Plano, Plano

75246

RECRUITING

Baylor Scott and White - Dallas, Dallas

76104

RECRUITING

Medical City of Fort Worth, Fort Worth

76508

RECRUITING

Baylor Scott and White - Temple, Temple

79601

RECRUITING

Hendrick Health, Abilene

80023

RECRUITING

ClinRe, Thornton

80401

RECRUITING

Colorado Heart and Vascular, Golden

90048

RECRUITING

Cedars Sinai, Los Angeles

90502

RECRUITING

Harbor UCLA, Torrance

91360

RECRUITING

HCA Los Robles, Thousand Oaks

91911

RECRUITING

CISD Sharp Chula Vista, Chula Vista

02114

RECRUITING

Beth Israel Deaconess, Boston

RECRUITING

Mass General, Boston

02115

RECRUITING

Brigham & Women's, Boston

01199

RECRUITING

Baystate Medical Center, Springfield

07631

RECRUITING

Englewood Health, Englewood

02903

RECRUITING

Lifespan Rhode Island & Miriam, Providence

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

NAMSA

OTHER

collaborator

Cordis Corporation

INDUSTRY

lead

M.A. Med Alliance S.A.

INDUSTRY

NCT05946629 - SELUTION 4 De Novo Small Vessel IDE Trial | Biotech Hunter | Biotech Hunter